{"drugs":["Meningococcal Polysaccharide Vaccine","Menomune-A\/C\/Y\/W-135"],"mono":{"0":{"id":"928370-s-0","title":"Generic Names","mono":"Meningococcal Polysaccharide Vaccine"},"1":{"id":"928370-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928370-s-1-4","title":"Adult Dosing","mono":"<b>Meningococcal infectious disease; Prophylaxis:<\/b> adults 56 years or older, not previously vaccinated, requiring a single vaccine dose: 0.5 mL SUBQ (guideline dose); 0.5 mL SUBQ as a single dose (manufacturer dose)."},"1":{"id":"928370-s-1-5","title":"Pediatric Dosing","mono":"<b>Meningococcal infectious disease; Prophylaxis:<\/b> (2 years or older) 0.5 mL SUBQ as a single dose (manufacturer dose); not routinely recommended for use in pediatric patients "},"3":{"id":"928370-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Meningococcal infectious disease; Prophylaxis<br\/>"}}},"3":{"id":"928370-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928370-s-3-9","title":"Contraindications","mono":"allergic reactions, severe (eg, anaphylaxis), after a previous dose of meningococcal polysaccharide vaccine or any component of the vaccine <br\/>"},{"id":"928370-s-3-10","title":"Precautions","mono":"<ul><li>acute allergic reactions and anaphylaxis may occur; appropriate supportive medical treatment should be readily available during treatment<\/li><li>acute illness with or without fever, moderate or severe; defer vaccination unless the benefit of protection outweighs the risk of an adverse reaction<\/li><li>concomitant immunosuppressive therapy; may have diminished immune response<\/li><li>immunosuppression; may have diminished immune response<\/li><li>latex allergy; vial stopper of lyophilized vaccine and diluent contain dry natural latex rubber<\/li><\/ul>"},{"id":"928370-s-3-11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>B2 (AUS)<\/li><\/ul>"},{"id":"928370-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"4":{"id":"928370-s-4","title":"Drug Interactions","sub":{"1":{"id":"928370-s-4-14","title":"Major","mono":"<ul><li>Cyclosporine (theoretical)<\/li><li>Measles Virus Vaccine, Live (probable)<\/li><\/ul>"}}},"5":{"id":"928370-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Injection site reaction<\/li><li><b>Endocrine metabolic:<\/b>Shivering<\/li><li><b>Neurologic:<\/b>Headache<\/li><li><b>Other:<\/b>Fever, Malaise<\/li><\/ul>"},"6":{"id":"928370-s-6","title":"Drug Name Info","sub":{"0":{"id":"928370-s-6-17","title":"US Trade Names","mono":"Menomune-A\/C\/Y\/W-135<br\/>"},"2":{"id":"928370-s-6-19","title":"Class","mono":"Vaccine<br\/>"},"3":{"id":"928370-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"928370-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"928370-s-7","title":"Mechanism Of Action","mono":"Meningococcal polysaccharide vaccine is a combination of group-specific (A,C,Y,W-135) polysaccharide antigens derived from Neisseria meningitidis used to aid body immunization against meningococcal infection by inducing bactericidal antibodies specific towards these serogroups.<br\/>"},"9":{"id":"928370-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>for subQ use only; do not give IV or IM<br\/><\/li><li><b>Subcutaneous<\/b><br\/><ul><li>withdraw supplied diluent (0.6 mL for single-dose presentation and 6 mL for multidose presentation) and inject into vial containing the lyophilized vaccine; swirl until thoroughly dissolved and vaccine is a clear, colorless liquid<\/li><li>do not combine through reconstitution or mix with any other vaccine<\/li><li>use single-dose immediately after reconstitution; multidose vials may be stored between 2 and 8 degrees C (35 and 46 degrees F) for up to 35 days after reconstitution<\/li><li>preferred site of administration is deltoid region<\/li><li>use separate sterile needle and syringe for each dose withdrawn from multidose vials<\/li><\/ul><\/li><\/ul>"},"11":{"id":"928370-s-11","title":"How Supplied","mono":"<b>Menomune-A\/C\/Y\/W-135<\/b><br\/>Subcutaneous Powder for Solution: 0.05 MG, 0.5 MG<br\/>"},"13":{"id":"928370-s-13","title":"Clinical Teaching","mono":"This drug may cause shivering, headache, fever, or malaise.<br\/>"}}}